161 related articles for article (PubMed ID: 2003327)
1. The critical role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease in immunocompetent patients.
Otsuka S; Kunieda K; Kitamura F; Misawa K; Sasaoka I; Hirose M; Kasuya S; Saji S; Noma A
Transfusion; 1991; 31(3):260-4. PubMed ID: 2003327
[TBL] [Abstract][Full Text] [Related]
2. Fatal erythroderma (suspected graft-versus-host disease) after cholecystectomy. Retrospective analysis.
Otsuka S; Kunieda K; Hirose M; Takeuchi H; Mizutani Y; Nagaya M; Sato G; Kasuya S; Matsutomo K; Noma A
Transfusion; 1989; 29(6):544-8. PubMed ID: 2526400
[TBL] [Abstract][Full Text] [Related]
3. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
Benson K; Marks AR; Marshall MJ; Goldstein JD
Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
[TBL] [Abstract][Full Text] [Related]
5. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
Shivdasani RA; Anderson KC
Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
[TBL] [Abstract][Full Text] [Related]
6. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
[TBL] [Abstract][Full Text] [Related]
7. Transfusion of peripheral blood stem cells from donor homozygous for a shared HLA-haplotype: avoiding fatal transfusion-associated graft-versus-host disease while preserving anti-leukemic effect.
Wong R; Lau FY; Chui CH; Tsang KS; Chik KW; Li CK; Cheng G
Transplantation; 2001 Feb; 71(3):487-90. PubMed ID: 11233917
[TBL] [Abstract][Full Text] [Related]
8. Transfusion associated graft versus host disease in an immunocompetent patient.
O'Connor NT; Mackintosh P
J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
[TBL] [Abstract][Full Text] [Related]
9. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)].
Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F
Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells.
Suzuki K; Akiyama H; Takamoto S; Maruyama Y; Sakamaki H; Akagi K; Maeda Y; Takenaka M; Onozawa Y
Transfusion; 1992 May; 32(4):358-60. PubMed ID: 1585443
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
Labotka RJ; Radvany R
Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
[TBL] [Abstract][Full Text] [Related]
12. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease.
McMilin KD; Johnson RL
Transfus Med Rev; 1993 Jan; 7(1):37-41. PubMed ID: 8431657
[TBL] [Abstract][Full Text] [Related]
13. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
Hovdenes J; Solheim BG
Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
[TBL] [Abstract][Full Text] [Related]
14. Transfusion-associated graft-versus-host disease and its prevention.
Williamson LM; Warwick RM
Blood Rev; 1995 Dec; 9(4):251-61. PubMed ID: 8839400
[TBL] [Abstract][Full Text] [Related]
15. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.
Thaler M; Shamiss A; Orgad S; Huszar M; Nussinovitch N; Meisel S; Gazit E; Lavee J; Smolinsky A
N Engl J Med; 1989 Jul; 321(1):25-8. PubMed ID: 2786605
[No Abstract] [Full Text] [Related]
16. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes.
Wagner FF; Flegel WA
Transfusion; 1995 Apr; 35(4):284-91. PubMed ID: 7701545
[TBL] [Abstract][Full Text] [Related]
17. [A case of fatal graft-versus-host disease following blood transfusion in esophageal cancer documented by homozygous changes of HLA typing].
Soeda K; Onoda S; Kozu T; Okuyama K; Koide Y; Isono K
Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1040-3. PubMed ID: 2233658
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery.
Rososhansky S; Badonnel MC; Hiestand LL; Popovsky MA; Szymanski IO
Vox Sang; 1999; 76(1):59-63. PubMed ID: 9933856
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?
Kanter MH
Transfusion; 1992 May; 32(4):323-7. PubMed ID: 1585436
[TBL] [Abstract][Full Text] [Related]
20. Potential for transfusion-associated graft-versus-host disease due to apheresis platelets matched for HLA class I antigens.
Grishaber JE; Birney SM; Strauss RG
Transfusion; 1993; 33(11):910-4. PubMed ID: 8259596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
